Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_assertion type Assertion NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_head.
- NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_assertion description "[Inhibitors of the PI3K pathway are in clinical testing in patients with solid tumors, including uterine cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_provenance.
- NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_assertion evidence source_evidence_literature NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_provenance.
- NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_assertion SIO_000772 21903247 NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_provenance.
- NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_assertion wasDerivedFrom befree-20150227 NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_provenance.
- NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_assertion wasGeneratedBy ECO_0000203 NP621575.RAAr2CS2XyXvAoOG2Vfm0dQ1ligHGOQX0SxLMI82OszLk130_provenance.